BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26425691)

  • 1. Associations between proteasomal activator PA28γ and outcome of oral squamous cell carcinoma: Evidence from cohort studies and functional analyses.
    Li J; Feng X; Sun C; Zeng X; Xie L; Xu H; Li T; Wang R; Xu X; Zhou X; Zhou M; Zhou Y; Dan H; Wang Z; Ji N; Deng P; Liao G; Geng N; Wang Y; Zhang D; Lin Y; Ye L; Liang X; Li L; Luo G; Jiang L; Wang Z; Chen Q
    EBioMedicine; 2015 Aug; 2(8):851-8. PubMed ID: 26425691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surrogate Prognostic Biomarkers in OSCC: The Paradigm of PA28γ Overexpression.
    Kontos CK
    EBioMedicine; 2015 Aug; 2(8):784-5. PubMed ID: 26425675
    [No Abstract]   [Full Text] [Related]  

  • 3. PA28γ acts as a dual regulator of IL-6 and CCL2 and contributes to tumor angiogenesis in oral squamous cell carcinoma.
    Liu S; Liu D; Zeng X; Wang J; Liu J; Cheng J; Lei K; Bai H; Ji N; Zhou M; Jiang L; Dan H; Li J; Chen Q
    Cancer Lett; 2018 Aug; 428():192-200. PubMed ID: 29702196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of PA28γ and U2AF1 in oral mucosal carcinogenesis.
    Yin F; Wang J; Zhao K; Xin C; Shi Y; Zeng X; Xu H; Li J; Chen Q
    Oral Dis; 2020 Jan; 26(1):53-61. PubMed ID: 31605415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Construction of an oral squamous cell carcinoma cell line for stable PA28γ overexpression].
    Xin C; Wang JK; Li J; Zeng X
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Feb; 38(1):6-10. PubMed ID: 32037759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RACK1 is an organ-specific prognostic predictor in OSCC.
    Liu S; Liu J; Wang J; Cheng J; Zeng X; Ji N; Li J; Chen Q
    Oral Oncol; 2018 Jan; 76():22-26. PubMed ID: 29290282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer.
    Xiong S; Zheng Y; Jiang P; Liu R; Liu X; Qian J; Gu J; Chang L; Ge D; Chu Y
    Br J Cancer; 2014 Jan; 110(2):353-62. PubMed ID: 24281003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. circFANCA accelerates the malignant process of OSCC by modulating miR-34a/PA28γ signaling.
    Ren Y; Pan K; Wang Y; Zhang S; Wang Y; Zhou X; Dan H; Chen Q; Ji N; Li J
    Biochem Biophys Res Commun; 2023 Jul; 665():45-54. PubMed ID: 37148744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.
    Wei H; Yu K; Liu Y; Li L; Wang G
    BMC Cancer; 2020 Aug; 20(1):756. PubMed ID: 32787801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of proteasomal activator PA28α serves as a prognostic factor in oral squamous cell carcinoma.
    Feng X; Jiang Y; Xie L; Jiang L; Li J; Sun C; Xu H; Wang R; Zhou M; Zhou Y; Dan H; Wang Z; Ji N; Deng P; Liao G; Geng N; Wang Y; Zhang D; Lin Y; Ye L; Liang X; Li L; Luo G; Feng M; Fang J; Zeng X; Wang Z; Chen Q
    J Exp Clin Cancer Res; 2016 Feb; 35():35. PubMed ID: 26892607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
    Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
    Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.
    Cheng AN; Jiang SS; Fan CC; Lo YK; Kuo CY; Chen CH; Liu YL; Lee CC; Chen WS; Huang TS; Wang TY; Lee AY
    Cancer Lett; 2013 Sep; 337(2):218-25. PubMed ID: 23684929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a BRAF/PA28γ/MEK1 signaling axis and its role in epithelial-mesenchymal transition in oral submucous fibrosis.
    Xie C; Li Z; Hua Y; Sun S; Zhong L; Chen Q; Feng H; Ji N; Li T; Zhou X; Zeng X; Tang Z; Sun C; Li J; Chen Q
    Cell Death Dis; 2022 Aug; 13(8):701. PubMed ID: 35961969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
    Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
    BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
    Guo H; Li C; Su X; Huang X
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of Immune-Related Risk Signatures for the Prognostic Prediction in Oral Squamous Cell Carcinoma.
    Zou C; Huang D; Wei H; Wu S; Song J; Tang Z; Li X; Ai Y
    J Immunol Res; 2021; 2021():6203759. PubMed ID: 34497859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PA28γ coordinates the cross-talk between cancer-associated fibroblasts and tumor cells to promote OSCC progression via HDAC1/E2F3/IGF2 signaling.
    Li Z; Sun S; Wang Y; Hua Y; Liu M; Zhou Y; Zhong L; Li T; Zhao H; Zhou X; Zeng X; Chen Q; Li J
    Cancer Lett; 2024 Jul; 594():216962. PubMed ID: 38768680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CDK7 is associated with unfavourable prognosis in oral squamous cell carcinoma.
    Jiang L; Huang R; Wu Y; Diao P; Zhang W; Li J; Li Z; Wang Y; Cheng J; Yang J
    Pathology; 2019 Jan; 51(1):74-80. PubMed ID: 30473182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.